Pfizer Loses Lipitor Patent Challenge At USPTO, But Hurdles Remain For Generic Makers
The U.S. Patent & Trademark Office has thrown out one of several patents that Pfizer holds on its blockbuster cholesterol lowering drug Lipitor....To view the full article, register now.
Already a subscriber? Click here to view full article